Because developing AIDS drugs for poor children is not profitable, many companies don?t even study the effects of existing or new adult antiretroviral drugs in children. We must make sure that the youngest people living with AIDS are not forgotten.
Get the latest updates on our work
How we use funds
1% Management & general